Cargando…
Cell membrane-coated nanomaterials for cancer therapy
With the development of nanotechnology, nanoparticles have emerged as a delivery carrier for tumor drug therapy, which can improve the therapeutic effect by increasing the stability and solubility and prolonging the half-life of drugs. However, nanoparticles are foreign substances for humans, are ea...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148189/ https://www.ncbi.nlm.nih.gov/pubmed/37128288 http://dx.doi.org/10.1016/j.mtbio.2023.100633 |
_version_ | 1785034945874362368 |
---|---|
author | Zeng, Shiying Tang, Qinglai Xiao, Minna Tong, Xinying Yang, Tao Yin, Danhui Lei, Lanjie Li, Shisheng |
author_facet | Zeng, Shiying Tang, Qinglai Xiao, Minna Tong, Xinying Yang, Tao Yin, Danhui Lei, Lanjie Li, Shisheng |
author_sort | Zeng, Shiying |
collection | PubMed |
description | With the development of nanotechnology, nanoparticles have emerged as a delivery carrier for tumor drug therapy, which can improve the therapeutic effect by increasing the stability and solubility and prolonging the half-life of drugs. However, nanoparticles are foreign substances for humans, are easily cleared by the immune system, are less targeted to tumors, and may even be toxic to the body. As a natural biological material, cell membranes have unique biological properties, such as good biocompatibility, strong targeting ability, the ability to evade immune surveillance, and high drug-carrying capacity. In this article, we review cell membrane-coated nanoparticles (CMNPs) and their applications to tumor therapy. First, we briefly describe CMNP characteristics and applications. Second, we present the characteristics and advantages of different cell membranes as well as nanoparticles, provide a brief description of the process of CMNPs, discuss the current status of their application to tumor therapy, summarize their shortcomings for use in cancer therapy, and propose future research directions. This review summarizes the research progress on CMNPs in cancer therapy in recent years and assesses remaining problems, providing scholars with new ideas for future research on CMNPs in tumor therapy. |
format | Online Article Text |
id | pubmed-10148189 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-101481892023-04-30 Cell membrane-coated nanomaterials for cancer therapy Zeng, Shiying Tang, Qinglai Xiao, Minna Tong, Xinying Yang, Tao Yin, Danhui Lei, Lanjie Li, Shisheng Mater Today Bio Review Article With the development of nanotechnology, nanoparticles have emerged as a delivery carrier for tumor drug therapy, which can improve the therapeutic effect by increasing the stability and solubility and prolonging the half-life of drugs. However, nanoparticles are foreign substances for humans, are easily cleared by the immune system, are less targeted to tumors, and may even be toxic to the body. As a natural biological material, cell membranes have unique biological properties, such as good biocompatibility, strong targeting ability, the ability to evade immune surveillance, and high drug-carrying capacity. In this article, we review cell membrane-coated nanoparticles (CMNPs) and their applications to tumor therapy. First, we briefly describe CMNP characteristics and applications. Second, we present the characteristics and advantages of different cell membranes as well as nanoparticles, provide a brief description of the process of CMNPs, discuss the current status of their application to tumor therapy, summarize their shortcomings for use in cancer therapy, and propose future research directions. This review summarizes the research progress on CMNPs in cancer therapy in recent years and assesses remaining problems, providing scholars with new ideas for future research on CMNPs in tumor therapy. Elsevier 2023-04-12 /pmc/articles/PMC10148189/ /pubmed/37128288 http://dx.doi.org/10.1016/j.mtbio.2023.100633 Text en © 2023 The Authors. Published by Elsevier Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Article Zeng, Shiying Tang, Qinglai Xiao, Minna Tong, Xinying Yang, Tao Yin, Danhui Lei, Lanjie Li, Shisheng Cell membrane-coated nanomaterials for cancer therapy |
title | Cell membrane-coated nanomaterials for cancer therapy |
title_full | Cell membrane-coated nanomaterials for cancer therapy |
title_fullStr | Cell membrane-coated nanomaterials for cancer therapy |
title_full_unstemmed | Cell membrane-coated nanomaterials for cancer therapy |
title_short | Cell membrane-coated nanomaterials for cancer therapy |
title_sort | cell membrane-coated nanomaterials for cancer therapy |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148189/ https://www.ncbi.nlm.nih.gov/pubmed/37128288 http://dx.doi.org/10.1016/j.mtbio.2023.100633 |
work_keys_str_mv | AT zengshiying cellmembranecoatednanomaterialsforcancertherapy AT tangqinglai cellmembranecoatednanomaterialsforcancertherapy AT xiaominna cellmembranecoatednanomaterialsforcancertherapy AT tongxinying cellmembranecoatednanomaterialsforcancertherapy AT yangtao cellmembranecoatednanomaterialsforcancertherapy AT yindanhui cellmembranecoatednanomaterialsforcancertherapy AT leilanjie cellmembranecoatednanomaterialsforcancertherapy AT lishisheng cellmembranecoatednanomaterialsforcancertherapy |